These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9415290)

  • 1. Gene therapy for arterial thrombosis.
    Vassalli G; Dichek DA
    Cardiovasc Res; 1997 Sep; 35(3):459-69. PubMed ID: 9415290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targets for gene therapy of vein grafts.
    Newby AC; Baker AH
    Curr Opin Cardiol; 1999 Nov; 14(6):489-94. PubMed ID: 10579065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human placental ectonucleoside triphosphate diphosphohydrolase gene transfer via gelatin-coated stents prevents in-stent thrombosis.
    Takemoto Y; Kawata H; Soeda T; Imagawa K; Somekawa S; Takeda Y; Uemura S; Matsumoto M; Fujimura Y; Jo J; Kimura Y; Tabata Y; Saito Y
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):857-62. PubMed ID: 19325141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of antithrombotic therapies in reducing synthetic small-diameter vascular graft thrombosis.
    Tatterton M; Wilshaw SP; Ingham E; Homer-Vanniasinkam S
    Vasc Endovascular Surg; 2012 Apr; 46(3):212-22. PubMed ID: 22308212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local gene delivery: arterial thrombosis model for endothelial cell-targeted thrombolytic gene therapy research.
    Shenaq SM; Kattash MM; Weinfeld AB; Waugh JM; Yüksel E; Yüksel M; Gura DH
    J Reconstr Microsurg; 1999 Jan; 15(1):73-9. PubMed ID: 10025534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery.
    Dörffler-Melly J; Büller HR; Koopman MM; Prins MH
    Cochrane Database Syst Rev; 2003; (4):CD000536. PubMed ID: 14583924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD
    Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic therapy and progression of coronary artery disease. Antiplatelet versus antithrombins.
    Chesebro JH; Webster MW; Zoldhelyi P; Roche PC; Badimon L; Badimon JJ
    Circulation; 1992 Dec; 86(6 Suppl):III100-10. PubMed ID: 1424043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent Thrombolytic Effect of
    Martinez de Lizarrondo S; Gakuba C; Herbig BA; Repessé Y; Ali C; Denis CV; Lenting PJ; Touzé E; Diamond SL; Vivien D; Gauberti M
    Circulation; 2017 Aug; 136(7):646-660. PubMed ID: 28487393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravascular ultrasound thrombolysis for recanalization of peripheral arteries: evaluation of an in vitro model and results of a pilot-study].
    Krüger K; Deissler P; Zähringer M; Coburger S; Gawenda M; Lackner K
    Rofo; 2002 Oct; 174(10):1261-8. PubMed ID: 12375200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic strategies in gene therapy.
    Channon KM; Annex BH
    Curr Cardiol Rep; 2000 Jan; 2(1):34-8. PubMed ID: 10980870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applied gene therapy in preclinical models of vascular injury.
    Janssens SP
    Curr Atheroscler Rep; 2003 May; 5(3):186-90. PubMed ID: 12667430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Post-implant antithrombotic treatment after intracoronary stents. Thrombotic occlusion].
    Alonso Martín JJ; Durán Hernández JM; Gimeno de Carlos F; de la Fuente Galán L; Muñoz San José JC; Fernández-Avilés F
    Rev Esp Cardiol; 1997; 50 Suppl 2():31-43. PubMed ID: 9221455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current trends in antithrombotic drug and device development.
    Fareed J
    Semin Thromb Hemost; 1996; 22 Suppl 1():3-8. PubMed ID: 8807721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model.
    Sharif F; Hynes SO; McCullagh KJ; Ganley S; Greiser U; McHugh P; Crowley J; Barry F; O'Brien T
    Gene Ther; 2012 Mar; 19(3):321-8. PubMed ID: 21716298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic therapy after intracoronary stenting.
    Spinler S; Cheng J
    Pharmacotherapy; 1997; 17(1):74-90. PubMed ID: 9017767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of intravascular thrombosis and vascular smooth muscle cell proliferation by gene therapy.
    Flugelman MY
    Thromb Haemost; 1995 Jul; 74(1):406-10. PubMed ID: 8578496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoplex gene transfer of inducible nitric oxide synthase inhibits the reactive intimal hyperplasia after expanded polytetrafluoroethylene bypass grafting.
    Pfeiffer T; Wallich M; Sandmann W; Schrader J; Gödecke A
    J Vasc Surg; 2006 May; 43(5):1021-7. PubMed ID: 16678699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulsed-spray thrombolysis of arterial and bypass graft occlusions.
    Valji K; Roberts AC; Davis GB; Bookstein JJ
    AJR Am J Roentgenol; 1991 Mar; 156(3):617-21. PubMed ID: 1825256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene delivery to pig coronary arteries from stents carrying antibody-tethered adenovirus.
    Klugherz BD; Song C; DeFelice S; Cui X; Lu Z; Connolly J; Hinson JT; Wilensky RL; Levy RJ
    Hum Gene Ther; 2002 Feb; 13(3):443-54. PubMed ID: 11860711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.